Biotinylated Monoclonal Anti-TNF-alpha Antibody, human IgG1 (16H5) (MALS verified)
抗體來源(Source)
Biotinylated Monoclonal Anti-TNF-alpha Antibody, human IgG1 (16H5) is a chimeric monoclonal antibody recombinantly expressed from HEK293, which combines the variable region of a mouse monoclonal antibody with Human constant domain.
克隆號(hào)(Clone)
16H5
亞型(Isotype)
Human IgG1 | Human Kappa
偶聯(lián)(Conjugate)
Biotin
抗體類型(Antibody Type)
Recombinant Monoclonal
種屬反應(yīng)性(Reactivity)
Human
免疫原(Immunogen)
Human TNF-alpha Protein is expressed from human 293 cells.
特異性(Specificity)
This product is a specific antibody specifically reacts with TNF-alpha.
應(yīng)用(Application)

純度(Purity)
>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
純化(Purification)
Protein A purified / Protein G purified
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.


背景(Background)
腫瘤壞死因子α(TNFα)是一種主要由單核細(xì)胞和巨噬細(xì)胞產(chǎn)生的細(xì)胞因子。它存在于組織中的滑膜細(xì)胞和巨噬細(xì)胞中。TNFα的主要作用是調(diào)節(jié)免疫細(xì)胞。TNFα能夠誘導(dǎo)凋亡細(xì)胞死亡,誘導(dǎo)炎癥,抑制腫瘤發(fā)生和病毒復(fù)制。TNFα產(chǎn)生的失調(diào)與多種人類疾病有關(guān),包括嚴(yán)重抑郁癥、阿爾茨海默病和癌癥。重組TNFα被用作國際非專利藥品名稱tasonermin下的免疫刺激劑。TNFα可以在惡性腫瘤的情況下異位產(chǎn)生,在引起繼發(fā)性高鈣血癥和與過量產(chǎn)生相關(guān)的癌癥中與甲狀旁腺激素相似。
關(guān)鍵字: TNF-alpha;TNF-alpha抗體;TNFα抗體;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。